Latest DEF 14A proxy statements

ServiceNow's 2026 proxy statement outlines key governance proposals, including an increase in equity incentive plan shares and a board recommendation against a shareholder proposal for written consent.

Travere Therapeutics has issued its 2026 proxy statement detailing proposals for director elections, an equity incentive plan amendment, and executive compensation advisory votes.

Kingsway Financial Services Inc. has issued its 2026 proxy statement detailing director elections, a corporate name change, and an expansion of its equity incentive plan.

Rocket Pharmaceuticals announces its 2026 Annual Meeting, seeking approval for director elections, auditor ratification, executive compensation, and a stock option exchange program.

Actuate Therapeutics, Inc. has scheduled its 2026 Annual Meeting of Stockholders for May 21, 2026, to vote on director elections and auditor ratification.

Insulet Corporation reports strong 2025 financial performance with 30% revenue growth and outlines strategic leadership transitions.

Enovis Corporation has issued its 2026 proxy statement, seeking stockholder approval for director elections, auditor ratification, executive compensation, and an amendment to its 2020 Omnibus Incentive Plan.

Steven Madden, Ltd. announces its 2026 Annual Meeting of Stockholders to be held virtually on May 20, 2026.

Trio Petroleum Corp seeks shareholder approval for a reverse stock split and an increase in shares reserved under its 2022 Equity Incentive Plan.

Middlesex Water Company outlines its 2025 financial performance, strategic infrastructure investments, and executive compensation ahead of its May 2026 Annual Meeting.

Principal Financial Group successfully completed its leadership transition while delivering record assets under management and returning $1.5 billion to shareholders in 2025.

Onto Innovation reports $1 billion in 2025 revenue and outlines executive compensation and governance updates ahead of its May 2026 stockholder meeting.

Femasys Inc. has called a special meeting for April 29, 2026, to seek shareholder approval for a reverse stock split and the issuance of shares related to convertible notes and warrants.

Bank of the James Financial Group, Inc. has issued its 2026 proxy statement for the annual meeting scheduled for May 19, 2026.

FS Bancorp, Inc. has issued its 2026 proxy statement detailing the upcoming annual meeting, including the proposal for a new 2026 Equity Incentive Plan.

Ares Dynamic Credit Allocation Fund, Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders to be held on June 4, 2026.

ServisFirst Bancshares, Inc. has released its 2026 proxy statement detailing the agenda for the upcoming annual meeting of stockholders on May 18, 2026.

FS Credit Real Estate Income Trust, Inc. has issued its definitive proxy statement for the 2026 Annual Meeting of Stockholders scheduled for July 1, 2026.

NN, Inc. has filed its definitive proxy statement with the SEC to facilitate shareholder voting on corporate matters.

United-Guardian, Inc. has scheduled its 2026 virtual Annual Meeting of Stockholders for May 13, 2026, to address director elections, executive compensation, and auditor ratification.

New Peoples Bankshares, Inc. has issued its 2026 proxy statement detailing director elections, executive compensation, and auditor ratification.

AtriCure, Inc. has released its 2026 proxy statement detailing proposals for director elections, executive compensation, and increases to equity incentive plans.

Gibraltar Industries' 2026 proxy statement outlines the upcoming annual meeting, director elections, and executive compensation philosophy.

River Financial Corporation has issued its proxy statement for the 2026 Annual Meeting of Stockholders scheduled for May 19, 2026.

Old Second Bancorp, Inc. has issued its 2026 proxy statement detailing the upcoming annual meeting of stockholders to be held virtually on May 19, 2026.

Meridian Corporation has issued its 2026 proxy statement detailing director elections, executive compensation, and auditor ratification for the upcoming annual meeting.

Chemed Corporation has issued its 2026 proxy statement detailing the upcoming annual meeting, director elections, and executive compensation advisory vote.

Treace Medical Concepts, Inc. has released its 2026 proxy statement detailing director elections, executive compensation, and auditor ratification.

NN, Inc. has filed its 2026 proxy statement, outlining proposals for director elections, executive compensation, and an amendment to its 2022 Omnibus Incentive Plan.

NBT Bancorp Inc. has issued its 2026 proxy statement detailing the upcoming virtual annual meeting, director elections, and executive compensation proposals.